THE EFFECT OF INDOLE-3-CARBINOL ON METABOLISM AND THE SAFETY OF ITS LONG-TERM USE IN WOMEN AT RISK

Abdusamatova D.Z.

Authors

Abdusamatova D.Z. Author

Abstract

Breast cancer (BC) is one of the leading oncological diseases among women worldwide. According to the World Health Organization (WHO), more than 2 million new cases are diagnosed every year, a significant portion of which are associated with hormonal imbalance and hereditary predisposition. Chemoprevention has become an important approach to reducing the risk of BC, particularly for women with high-risk factors such as a family history of the disease, genetic mutations (BRCA1/2), and hormonal disorders.

References

1. Kassahun BT, Li M, Liu Z, et al. Indole-3-carbinol suppresses estrogen-induced mammary tumorigenesis by modulating estrogen metabolism and signaling pathways. Cancer Prev Res (Phila). 2022;15(3):177–189.

2. Zhu W, Zhang L, Chen X, et al. Indole-3-carbinol enhances estrogen metabolism and inhibits proliferation in breast cancer cells via regulation of CYP1A1 expression. Front Pharmacol. 2021;12:636878.

3. Chang JH, Kim MH, Rhee Y. Dietary indole-3-carbinol modulates estrogen metabolism and prevents hormone-dependent tumorigenesis. Nutrients. 2020;12(4):1001.

4. Tesei A, Zamagni A, Arienti C, et al. Indole-3-carbinol and its derivatives: novel modulators of estrogen metabolism and breast cancer progression. Pharmaceuticals. 2022;15(2):205.

5. Chen D, Banerjee S, Cui Q, Kong AN. Isoflavones and indole-3-carbinol regulate estrogen-metabolizing enzymes and prevent estrogen-mediated breast carcinogenesis. Mol Nutr Food Res. 2020;64(1):e1900592.

6. Weng JR, Tsai CH, Kulp SK, Chen CS. Indole-3-carbinol as a chemopreventive and anti-cancer agent. Cancer Lett. 2021;496:20–31.